Stadgentri is a topical cream combining the anti-inflammatory, antipruritic actions of betamethasone with the antifungal activity of clotrimazole and the broad-spectrum antibiotic activity of gentamicin sulfate.

Pack size Box of 1 tube of 10 g, 20 g
Shelf-life 24 months
Composition Betamethasone Dipropionate, Gentamicin (sulfate), Clotrimazole.
Dosage forms and strengths Topical cream:

Tube 10 g consists of Betamethasone dipropionate 6.4 mg, Gentamicin (sulfate) 10 mg, Clotrimazole 100 mg).

Tube 20 g consists of Betamethasone dipropionate 12.8 mg, Gentamicin (sulfate) 20 mg, Clotrimazole 200 mg).
Product code :



Corticosteroid-responsive dermatoses when complicated by infections caused by bacteria and fungi or when the possibility of such infections is suspected; oozing eczema.


Apply twice daily, morning and evening. Duration of therapy varies depending upon the extent and location of disease and patient response.


Apply sparingly a thin film of cream to the affected skin areas. This cream should be applied regularly.

Known hypersensitivity to any of the active substances or excipients.

Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria, mild burning, stinging to skin.

  • Avoid contact with the eyes, the mouth, or intravaginally.
  • Patients under the age of 17 years, in diaper dermatitis and under occlusion.
  • Conditions include use over large surface area, prolonged use and use under occlusive dressings augment systemic absorption of topical corticosteroids, which has produced reversible hypothalamic – pituitary – adrenal (HPA) axis suppression, manifestations of Cushing’s syndrome, hyperglycemia and glucosuria: an attempt should be made to withdraw the drug, to reduce the frequency of application, or to substitute a less potent corticosteroid.
  • The possibility of cumulative toxicity should be considered if gentamicin is applied topically to large skin lesions or large areas of denuded skin in combination with systemic aminoglycoside therapy.
  • Pregnancy: only use if the potential benefit justifies the potential risk to the foetus. The drug should not be used on extensive areas, in large amounts or for prolonged periods. Lactation: a decision should be made to discontinue nursing or to discontinue the drug.